| 标题 |
Four-Year Outcomes of First-Line Nivolumab Plus Ipilimumab for 6 Months Versus Continuation in Patients With Advanced NSCLC: Results of the Randomized IFCT-1701 “DICIPLE” Phase III Trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:Journal of Thoracic Oncology 作者:G. Zalcman; A. Madroszyk; E. Guenzi; C. Dayen; Olivier Molinier; et al 出版日期:2026-02-01 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人或该文件上传人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)